Sign In
Buy LLY
$1,131.42
+6.15 (+0.547%)
At Close: Jun 05, 2026
Lilly appoints Lucas Montarce as executive vice president and chief financial officer
06:45am, Monday, 09'th Sep 2024
INDIANAPOLIS , Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO) and memb
Glucagon-like peptide-1 (GLP-1) agonists such as Mounjaro and Zepbound have been multibillion-dollar hits for Lilly, and their growth could just be getting started. Lilly is about to enter the Alzheim
Beyond Mounjaro and Zepbound: 6 Other Drugs That Could Be Blockbusters for Eli Lilly
05:42am, Sunday, 08'th Sep 2024
Eli Lilly has three likely blockbuster drugs that are relatively new to the market. Its pipeline features three other late-stage candidates with blockbuster potential.
Is Merck Stock Undervalued After Its Colossal Earnings Growth?
08:00am, Saturday, 07'th Sep 2024
Merck & Co., Inc. NYSE: MRK is one of the largest pharmaceutical firms in the world. The firm ranks fourth behind giants like Eli Lilly NYSE: LLY and Novo Nordisk NYSE: NVO, with a market capitalizati
Prediction: These 3 Stocks Will Outperform NVIDIA in 2025
03:38pm, Friday, 06'th Sep 2024
Unless you have been living under the rock, you'd have heard of Nvidia's (NASDAQ: NVDA) success story.
Four Biotech Stocks Rally Toward Buy Points As Funds Load Up
01:31pm, Friday, 06'th Sep 2024
Biotech stocks have been rallying as funds load up. Five stocks have been outperforming the vast majority in the IBD database.
The Big 3: LLY, XOM & PLTR
01:07pm, Friday, 06'th Sep 2024
Joe Tigay joins Ben Lichtenstein and Nicole Petallides to break down the technical trends in Eli Lilly (LLY), Exxon Mobil (XOM), and Palantir (PLTR). ======== Schwab Network ======== Empowering every
Eli Lilly's Weekly Insulin Shot Meets Two Late-Stage Study Goals
12:51pm, Friday, 06'th Sep 2024
Data from two late-stage studies show that LLY's once-weekly insulin injections achieved results that are similar to daily insulin shots.
Stock Of The Day: Here's Why Weight-Loss Drug Maker Eli Lilly Has Reversed
11:25am, Friday, 06'th Sep 2024
When stocks rally, they tend to run into resistance if they reach a price level that had been resistance before. And sometimes, after hitting it they reverse and head lower.
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:06am, Friday, 06'th Sep 2024
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Health Rounds: Next generation Lilly weight-loss drug shows added heart, liver benefits
04:40am, Friday, 06'th Sep 2024
Eli Lilly's experimental next generation weight-loss drug mimics three hormones instead of just one or two and continues to show promising clinical trial results for additional health benefits, the co
This Big Move by Eli Lilly May Solve the Weight Loss Drug Market's Biggest Problem
04:35am, Friday, 06'th Sep 2024
Eli Lilly's weight loss drugs are bringing in billions of dollars in revenue, and their performance even prompted the company to increase its annual revenue guidance. But one thing has limited the rev
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
02:47pm, Thursday, 05'th Sep 2024
Eli Lilly could be on its way to topping $1 trillion in market value. Meanwhile, Abbott launches its first over-the-counter continuous glucose monitor in U.S.
Eli Lilly and Company (LLY) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
01:31pm, Thursday, 05'th Sep 2024
Eli Lilly and Company (NYSE:LLY ) Morgan Stanley 22nd Annual Global Healthcare Conference Call September 5, 2024 7:45 AM ET Company Participants Jacob Van Naarden - Executive Vice President & Presiden
Eli Lilly signs research deal with AI-focused Genetic Leap
09:33am, Thursday, 05'th Sep 2024
Eli Lilly has entered into a research deal with artificial intelligence-focused firm Genetic Leap for up to $409 million to develop genetic medicines, the latter said on Thursday.
